Abstract
Up to 30% of the general population develops IgE against cross-reactive carbohydrate determinants (CCDs) found in insect venoms and plants and as a result are at risk of receiving false positive test results from specific IgE (sIgE) immunoassays. ImmunoCAP utilizes a cellulose-based matrix that is known to contain CCD N-glycans that bind to anti-CCD IgE antibodies. This abstract reports on the analysis and resolution of discordant results between NOVEOS and ImmunoCAP in two recent United Kingdom based National External Quality Assessment Service (UK NEQAS) samples.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
